International Business Machines CORP Form 4 insider transactions
NYSE
IBM Director Michelle J. Howard acquired 50 shares of common stock at $237.8293 per share through a pre-arranged 10b5-1 plan.
NYSE
IBM Director Michael Miebach acquired 434 shares of common stock at a weighted average price of $233.3261 per share.
NYSE
IBM Vice Chairman Gary D. Cohn reported the vesting and subsequent tax-related disposition of restricted stock units, increasing his direct beneficial ownership.
NYSE
IBM's Senior VP and CFO, James J. Kavanaugh, reported routine acquisitions of common stock through RSU vesting and corresponding tax-related sales.
NYSE
IBM Chairman and CEO Arvind Krishna increased his direct beneficial ownership of IBM common stock following the vesting of restricted stock units and subsequent tax-related dispositions.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, reported routine acquisitions and dispositions of common stock related to restricted stock unit vesting.
NYSE
IBM Senior Vice President Nickle Jaclyn Lamoreaux reported the vesting of restricted stock units and subsequent tax-related share dispositions.
NYSE
IBM Senior Vice President Robert David Thomas reported the vesting of restricted stock units and associated share transactions, including tax withholdings, on February 21, 2026.
NYSE
IBM's Senior VP and CFO, James J. Kavanaugh, reported the vesting of restricted stock units and a subsequent tax-related sale of common stock.
NYSE
IBM Chairman and CEO Arvind Krishna reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NYSE
IBM Senior Vice President Anne Robinson reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.
NYSE
IBM Senior Vice President Nickle Jaclyn Lamoreaux reported the vesting of restricted stock units and subsequent sale of shares for tax obligations.
NYSE
IBM Senior Vice President Robert David Thomas reported the vesting of restricted stock units and related share transactions, adjusting his beneficial ownership.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, reported the vesting of 696 restricted stock units and the subsequent sale of 353 shares for tax obligations.
NYSE
IBM Vice Chairman Gary D. Cohn reported the vesting of 2,322 restricted stock units and the subsequent sale of 1,285 shares for tax purposes.
NYSE
IBM CEO Arvind Krishna reported the vesting of performance share units and subsequent stock transactions, including the acquisition of 83,028 shares and the disposition of 41,133 shares for tax purposes.
NYSE
IBM Senior Vice President Nickle Jaclyn Lamoreaux reported the vesting of performance share units and subsequent tax-related stock disposition.
NYSE
IBM Senior Vice President Anne Robinson reported the vesting of performance share units and a subsequent sale of shares for tax purposes, effective February 1, 2026.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, reported the vesting of performance share units and a subsequent tax-related sale of common stock.
NYSE
IBM Vice Chairman Gary D. Cohn increased his direct beneficial ownership of IBM common stock by 16,299 shares following the vesting of performance share units.
NYSE
IBM's Senior VP and CFO, James J. Kavanaugh, increased his direct beneficial ownership of company common stock following the vesting of performance share units.
NYSE
IBM Senior Vice President Robert David Thomas reported the vesting of performance share units and subsequent sale of shares for tax purposes.
NYSE
IBM Director David Farr reported a planned future purchase of 1,000 shares of common stock at $304 per share, effective January 30, 2026, under a 10b5-1 plan.
NYSE
IBM Director Thomas Buberl deferred fees into 309 Promised Fee Shares, increasing his beneficial ownership to 13,808 derivative securities.
NYSE
IBM Director Peter R. Voser deferred fees into 338 Promised Fee Shares on December 31, 2025, increasing his total beneficial ownership to 31,422 derivative securities.
NYSE
IBM Director Michelle J. Howard has deferred a portion of her compensation into 278 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Michael Miebach defers compensation into 309 Promised Fee Shares, increasing his beneficial ownership of derivative securities to 3,529.
NYSE
IBM Director Martha E. Pollack reported a future deferral of fees into the company's equity compensation plan, acquiring 199 Promised Fee Shares.
NYSE
IBM Director Marianne Catherine Brown acquired 309 Promised Fee Shares as deferred compensation under the company's equity award plan.
NYSE
IBM Director Frederick H. Waddell defers 330 shares into the company's deferred compensation and equity award plan, increasing his beneficial ownership.